Dogwood Starts Halneuron Phase 2b Study in Chemo Neuropathy
18 May 2026 //
GLOBENEWSWIRE
Dogwood Therapeutics Ongoing Halneuron Trial at 50%; Top Results
02 Feb 2026 //
GLOBENEWSWIRE
Dogwood CMO To Present Halneuron Pain Program at Confernce
07 Oct 2025 //
PHARMIWEB
Could a pufferfish toxin be a safe alternative to opioids?
12 Jun 2019 //
FIERCE BIOTECH

Market Place
Sourcing Support